Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors — Michael Maes (2011) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors
Shared by
Michael Maes
University of Electronic Science and Technology of China
(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors
Editorial Material
2011
en
Authors
+9 more
Michael Maes
University Of Electronic Science & Technology Of China
BL
Brian E. Leonard
AF
Alberto Fernández‐Teruel
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Chapter in a book
2018
Pathways Driving Neuroprogression in Depression: The Role of Immune Activation
Giovanni Oriolo
,
Iría Grande
,
Rocio Martín‐Santos
,
Eduard Vieta
,
André F. Carvalho
Article
2008
The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression.
Michael Maes
Article
2008
The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression.
Michael Maes
Preprint
2025
Neuro-immune, metabolic, and oxidative pathways in depression due to hypothyroidism and Hashimoto’s thyroiditis
Sahira Qasim Al-Baldawi
,
Hussein Kadhem Al‐Hakeim
,
Ikram Khémiri
,
Michael Maes
Chapter in a book
2019
Depression and neuroprogression: Sirtuins and mitochondria as crucial hubs
George Anderson
,
Michael Maes
Discussion(0)
No comments yet. Be the first to comment.